N@N

Market Maker Surveillance Report. WAMKQ, UPI, SWS, GERN, TLB, XING, Losing Stocks With Lowest Price Friction For Tuesday, Dece

^{Published on 2010-12-07 19:00:33, Last Modified on 2010-12-22 19:35:46 - WOPRAI}
 

December 7, 2010 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 2775 companies with "abnormal" market making, 2536 companies with positive Friction Factors and 2746 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Tuesday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Washington Mutual De (OTC:WAMKQ), UROPLASTY INC (NASDAQ:UPI), SWS GROUP INC (NYSE:SWS), GERON CORP (NASDAQ:GERN), TALBOTS INC (NYSE:TLB), QIAO XING UNIVERSAL RESOURCE (NASDAQ:XING). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

     Symbol     Change       Percent      Buy Volume      Buy %%       Sell Volume     Sell %%      Net Volume      Friction
     WAMKQ      $-0.120      -18.38%      63,199          27.07%       102,584         43.95%       -39,385         -3,296  
     UPI        $-0.970      -18.44%      750,545         39.84%       1,100,904       58.44%       -350,359        -3,612  
     SWS        $-0.690      -14.35%      779,353         36.84%       1,149,258       54.33%       -369,905        -5,361  
     GERN       $-1.100      -17.97%      8,446,798       45.21%       10,167,249      54.42%       -1,720,451      -15,640 
     TLB        $-2.580      -22.65%      12,843,357      44.10%       13,517,198      46.41%       -673,841        -2,612  
     XING       $-0.280      -13.93%      1,023,198       39.07%       1,591,438       60.78%       -568,240        -20,294 

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net dollar losses (Change) and extremely low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows XING with a dollar loss Tuesday of $-0.28000 and a Friction Factor of -20,294 shares. That means that it only took 20,294 more shares of selling than buying to move XING lower by one penny. This means the Market Makers are allowing the stock to drop quickly (low friction). The combination of low friction and negative market direction can drive prices lower faster than normal.

Washington Mutual De (OTC:WAMKQ) - Washington Mutual De

UROPLASTY INC (NASDAQ:UPI) - Uroplasty, Inc., a medical device company, engages in the development, manufacture, and marketing of products for the treatment of voiding dysfunctions. The company offers Urgent PC system, a minimally invasive and office-based neurostimulation therapy for the treatment of urinary symptoms, such as urinary urgency, urinary frequency, and urge incontinence associated with overactive bladder; and Macroplastique, a minimally invasive, implantable soft tissue urethral bulking agent for the treatment of adult female stress urinary incontinence. It also provides PTQ Implants, which offer minimally-invasive and soft-textured permanent implant for treatment of fecal incontinence; and VOX Implants, a tissue bulking material for otolaryngology vocal cord rehabilitation applications, as well as distributes wound care products. The company offers its products primarily to urologists, urogynecologists, and gynecologists through direct field sales personnel and independent sales representatives in the United States, as well as through direct sales organization in the United Kingdom and the Netherlands, and through distributors in other markets. Uroplasty, Inc. was incorporated in 1992 and is headquartered in Minnetonka, Minnesota.

SWS GROUP INC (NYSE:SWS) - SWS Group, Inc., through its subsidiaries, provides various financial services in the United States. The company operates in four segments: Clearing, Retail, Institutional, and Banking. The Clearing segment provides clearing and execution services for general securities broker/dealers, bank affiliated firms, and firms specializing in high volume trading. The Retail segment includes retail securities products and services, such as equities, mutual funds, and fixed income products; insurance products; and managed accounts. The Institutional brokerage segment serves institutional customers in securities lending, investment banking and public finance, fixed income sales and trading, proprietary trading, and agency execution services. The Banking segment offers various banking products and services, including certificates of deposit, money market accounts, interest-bearing demand accounts, savings accounts, federal home loan bank advances, federal funds purchased, and non interest-bearing demand accounts, as well as 1-4 family residential loans and construction loans, land and land development loans, commercial real estate loans, commercial loans, and consumer loans. The company was founded in 1972 and is headquartered in Dallas, Texas.

GERON CORP (NASDAQ:GERN) - Geron Corporation, a biopharmaceutical company, develops biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, and diabetes. It develops a range of anti-cancer therapies based on telomerase inhibitors and telomerase therapeutic vaccines; and diagnostics based on telomerase detection, as well as intends to develop products using telomerase as a marker for cancer diagnosis, prognosis, patient monitoring, and screening. The company develops Imetelstat (GRN163L), which is in Phase I clinical trial for the treatment of chronic lymphoproliferative diseases, solid tumors, multiple myeloma, and non-small cell lung cancer. GRN163L is also in Phase I/II clinical trial to treat breast cancer. The company also develops GRNVAC1 that is in Phase II clinical trial for the treatment of acute myelogenous leukemia. It also develops GRNOPC1, which is in Phase I Trial for treatment of spinal cord injury; and GRNCM1 that is in preclinical stage to treat heart disease and screening. The company has licensing agreement with Merck & Co. to develop telomerase cancer vaccine, which is in Phase I clinical trial for the treatment of prostate and solid tumors; and Sienna Cancer Diagnostics to develop a preclinical stage product for the treatment of bladder cancer. Geron Corporation was founded in 1990 and is based in Menlo Park, California.

TALBOTS INC (NYSE:TLB) - The Talbots, Inc., together with its subsidiaries, operates as a specialty retailer and direct marketer of womens apparel, accessories, and shoes in the United States and Canada. It offers classic sportswear, casual wear, dresses, coats, sweaters, accessories, and shoes in misses, petites, woman, and woman petite sizes. The company also markets its products online through its Web site, talbots.com, as well as through catalogs. As of January 30, 2010, it operated 580 stores under the Talbots brand name. The company was founded in 1947 and is headquartered in Hingham, Massachusetts.

QIAO XING UNIVERSAL RESOURCE (NASDAQ:XING) - Qiao Xing Universal Resources, Inc. operates as an emerging resources company in China. The company, through its subsidiary, China Luxuriance Jade Company, Ltd, owns the rights to receive the expected residual returns from Chifeng Haozhou Mining Co., Ltd., a copper-molybdenum poly-metallic mining company in Inner Mongolia, China. Previously, it was engaged in telecommunication terminal products business and changed its focus to the resources industry in 2007. The company was formerly known as Qiao Xing Universal Telephone, Inc. and changed its name to Qiao Xing Universal Resources, Inc. in May 2010. Qiao Xing Universal Resources, Inc. was founded in 1992 and is headquartered in Huizhou, China.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net